LUMBY, British Columbia, April 15, 2009 (GLOBE NEWSWIRE) -- avVaa World Health Care Products Inc. (Pink Sheets:AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products announced that avVaa founders Jack Farley and Lorie Campbell-Farley have completed negotiations with a direct response TV, a multimedia production company that specializes in 120, 60, 30, 10 second short version infomercials dedicated to launching avVaa's core products. Their direct response team is responsible for generating over 400 million dollars in direct response television sales.
The objective in the first 12-month period is to complete up to three 120-second commercials in an infomercial format, with the objective to produce an infomercial intended to generate product sales, while at the same time increasing public awareness of the product. In addition, the program will concurrently act as a lead generation tool for follow-up sales, as well as creating brand awareness to help generate new retail opportunities.
avVaa's 1st infomercial will be Neuroskin(r) Psoriasis Relief by avVaa. Nearly 40 million Americans suffer from some type of skin disorder and because the skin is so visible, these disorders can result in unpleasant psychological and physical side-effects. Neuroskin(r) Psoriasis Relief was created from patented skin care science, developed to relieve symptoms of psoriasis, seborrheic dermatitis or itchy skin and is available to patients without a prescription.
avVaa's 2nd infomercial will be dermalustre(r) by avVaa, the all natural treatment, with no harmful chemicals, for companion animals in the dermal care category. Both Equine and Pet Industry professionals recommend dermalustre(r) as an excellent conditioner, repairing dry brittle coats, manes and tails, and relieving dry, itchy and flaky skin. dermalustre(r) is a one-step professional skin and coat treatment product with added benefits of a grooming spray that produces a bright healthy shine to the coat.
Specifics of the agreement with the media production company and time lines to produce the first infomercial will be announced by the end of April. "We are on track to meet all goals and timelines and are committed to enhancing shareholder value by utilizing Companies such as the Steve Allen Media Public Relations Agency and AllPennyStocks.com Media, Inc. to spread the word about avVaa and our products while we push ahead during this important time for our Company. We feel that with our IR/PR push and clear path for the launch of our Neuroskin Psoriasis Relief in national infomercials, we are on track for significant revenues in the second half of 2009," stated Lorie Campbell-Farley, President/COO of avVaa Health Care Products Inc.
Investors are encouraged to review an interview about avVaa World Health Care and avVaa's Product Line by Alexander M Haig, Jr. with Jack Farley, Dr. Mark Alden and Lorie Campbell-Farley.
Health Journal Television: http://video.google.com/videoplay?docid=8849965714335206838
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(r) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com http://www.avvaa.com
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature.
Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.